Associate Director, Global Medical Cardiovascular & Immunology, Medical Communications – Pulmonary Fibrosis

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

Position reports to the Director of Medical Communications within Global Medical Cardiovascular & Immunology, Global Medical Affairs and is responsible for leading the strategy and execution of publication plans for the pulmonary fibrosis (IPF/PPF) program. This role will ensure the disclosure and scientific content of the data and health economic value of BMS products and research data to inform Healthcare Providers, Patients, and Payers in accordance with local regulations.

Pulmonary fibrosis is at a pivotal moment, as new mechanisms enter a field that saw few new treatment options for more than a decade. The Associate Director will own the strategic rationale behind our publication, and to some extent scientific content, plans: assessing the scientific and competitive landscape, identifying evidence gaps, and determining where, when, and how BMS data are communicated to differentiate our program and build credibility with the interstitial lung disease (ILD) community. In practice, this means deciding which clinical trial results and analyses are published, in which peer-reviewed journals and at which medical conferences, and working with physician authors and agency partners to develop the manuscripts, abstracts, and presentations that communicate them.

This is an individual contributor role that leads through influence across cross-functional and matrix teams, combining strategic leadership with hands-on development of publications and scientific content alongside agency partners.

Key Responsibilities:

The Associate Director of Medical Communications is accountable for the following:

Medical Communications Strategy

• Maintaining a deep, current understanding of the pertinent scientific and competitive landscape, including competitor data disclosures, publication patterns, congress/conference activity, and emerging evidence standards (e.g., endpoints, combination/background therapy data, patient-reported outcomes).

• Conducting publication (and content) gap analyses and competitive publication audits to identify where BMS evidence can address unmet scientific needs and differentiate our program; translating findings into prioritized, evidence-based recommendations.

• Developing and defending the strategic rationale for journal and congress/conference selection (audience, reach, timing, impact, competitive positioning) beyond defaulting to precedent.

• Shaping and owning the pull-through of the Scientific Narrative and Communication Platform, ensuring publications and content tell a cohesive, differentiated story across the asset/medicine lifecycle and address communication needs across markets.

• Translating strategy into a clear, viable, and functionally integrated publication and content plan, aligned with the therapeutic area (TA)-specific Medical Communications strategy and overall Medical vision and objectives.

• Developing publications and scientific content (e.g., manuscripts, abstracts, congress/conference presentations, internal and external scientific materials) in partnership with authors and agencies, ensuring scientific accuracy, quality, and timely delivery.

Data Dissemination

• Serving as a subject matter expert to BMS internal audiences related to communication landscape, HCP preferences, publication and scientific content planning, data disclosure / dissemination, and representing BMS scientific communications to external investigators, key authors and journal editors.

• Leading internal process improvements to ensure BMS remains an ethical and credible leader in the practice of publications & scientific content; leading transformation efforts and ensuring BMS publication & scie...

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.